RPRX Royalty Pharma plc Stock Quote

RPRX [NASD]

Index	-	P/E	-	EPS (ttm)	-	Insider Own	17.50%	Shs Outstand	370.00M	Perf Week	1.33%
Market Cap	31.46B	Forward P/E	19.17	EPS next Y	2.71	Insider Trans	-6.83%	Shs Float	83.12M	Perf Month	18.47%
Income	-	PEG	-	EPS next Q	0.75	Inst Own	44.40%	Short Float	16.00%	Perf Quarter	22.29%
Sales	2.01B	P/S	15.67	EPS this Y	70.50%	Inst Trans	4.40%	Short Ratio	4.98	Perf Half Y	17.56%
Book/sh	12.03	P/B	4.32	EPS next Y	10.66%	ROA	-	Target Price	52.14	Perf Year	-
Cash/sh	4.51	P/C	11.51	EPS next 5Y	7.10%	ROE	-	52W Range	34.80 - 56.50	Perf YTD	3.80%
Dividend	0.60	P/FCF	-	EPS past 5Y	-	ROI	21.30%	52W High	-8.05%	Beta	-
Dividend %	1.15%	Quick Ratio	10.30	Sales past 5Y	-	Gross Margin	-	52W Low	49.28%	ATR	2.18
Employees	35	Current Ratio	10.30	Sales Q/Q	17.70%	Oper. Margin	-	RSI (14)	65.20	Volatility	4.33% 4.53%
Optionable	Yes	Debt/Eq	1.31	EPS Q/Q	208.30%	Profit Margin	-	Rel Volume	1.62	Prev Close	51.25
Shortable	Yes	LT Debt/Eq	1.31	Earnings	Nov 11 BMO	Payout	-	Avg Volume	2.67M	Price	51.95
Recom	2.40	SMA20	7.30%	SMA50	17.05%	SMA200	19.17%	Volume	4,320,198	Change	1.37%

Nov-09-20

Upgrade

UBS

Neutral → Buy

$52 → $51

Jul-14-20

Initiated

Evercore ISI

In-line

Jul-13-20

Initiated

UBS

Neutral

$52

Jul-13-20

Initiated

SunTrust

Buy

$56

Jul-13-20

Initiated

Morgan Stanley

Equal-Weight

$51

Jul-13-20

Initiated

JP Morgan

Neutral

$50

Jul-13-20

Initiated

Goldman

Neutral

$47

Jul-13-20

Initiated

Cowen

Outperform

$55

Jul-13-20

Initiated

Citigroup

Neutral

$50

Jul-13-20

Initiated

BofA Securities

Buy

$55

Jan-08-21 08:05AM	Royalty Pharma increases quarterly dividend by 13% to 17 cents a share MarketWatch
08:00AM	Royalty Pharma Announces 13% Dividend Increase GlobeNewswire
Jan-07-21 04:15PM	Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 12 GlobeNewswire
Dec-23-20 03:16PM	IPOs to watch in 2021: The 5 most anticipated debuts Yahoo Finance
Dec-22-20 08:30AM	Royalty Pharma Announces Charitable Gifts to Support COVID-19 Research at Leading Hospitals and Universities GlobeNewswire +5.07%
Dec-21-20 08:12AM	Royalty Pharma Announces Expansion of Leadership Team GlobeNewswire
Dec-17-20 04:29PM	Is RPRX A Good Stock To Buy Now? Insider Monkey
Dec-07-20 08:45AM	Royalty Pharma Acquires Royalty Interest in ORLADEYO and BCX9930 From BioCryst Pharmaceuticals GlobeNewswire
08:40AM	BioCryst Announces $325 Million of Funding from Royalty Pharma and Athyrium Capital Management GlobeNewswire
Dec-04-20 04:31PM	Biotech, Life Sciences IPOs Score Double-Digit Gains Barrons.com
Nov-16-20 03:39AM	Can Royalty Pharma plc's (NASDAQ:RPRX) ROE Continue To Surpass The Industry Average? Simply Wall St.
Nov-10-20 05:40PM	Royalty Pharma Reports Third Quarter 2020 Results GlobeNewswire
Nov-02-20 07:30AM	Royalty Pharma Acquires Additional Royalty Interest From the Cystic Fibrosis Foundation GlobeNewswire
Oct-20-20 04:32PM	Royalty Pharma Announces Closing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders GlobeNewswire
Oct-19-20 09:00AM	Royalty Pharma to Announce Third-Quarter 2020 Financial Results on November 11, 2020 GlobeNewswire
Oct-15-20 11:45PM	Royalty Pharma Announces Pricing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders GlobeNewswire
09:15AM	Royalty Pharma Declares Fourth-Quarter 2020 Dividend GlobeNewswire
Oct-13-20 04:10PM	Royalty Pharma Announces Secondary Offering of Class A Ordinary Shares by Selling Shareholders GlobeNewswire
Oct-02-20 07:00AM	New Ventures Funds Rebrands as Scientia Ventures PR Newswire
Sep-16-20 11:42AM	Royalty Pharma plc (NASDAQ:RPRX) Shares Could Be 41% Below Their Intrinsic Value Estimate Simply Wall St.
Sep-02-20 04:25PM	Royalty Pharma Announces Closing of $6.0 Billion Senior Unsecured Notes GlobeNewswire
08:00AM	Royalty Pharma Declares Third-Quarter 2020 Dividend GlobeNewswire
Aug-25-20 08:14AM	Royalty Pharma prices $6 billion bond deal that is its first as a public company MarketWatch
08:00AM	Royalty Pharma Announces Pricing of $6.0 Billion Senior Unsecured Notes GlobeNewswire
Aug-19-20 09:00AM	Royalty Pharma Announces Launch of Senior Notes Offering GlobeNewswire
Aug-12-20 07:00AM	Royalty Pharma Reports Second Quarter 2020 Results GlobeNewswire
Aug-07-20 09:40AM	Biohaven and Royalty Pharma Announce Funding Agreement Totaling up to $450 Million GlobeNewswire
Aug-03-20 04:15PM	Royalty Pharma Appoints Henry A. Fernandez and Ted W. Love, M.D. to the Companys Board of Directors GlobeNewswire
Jul-20-20 04:15PM	Royalty Pharma to Announce Second-Quarter 2020 Financial Results on August 12 GlobeNewswire
07:45AM	Royalty Pharma Acquires Royalty Interest in Risdiplam From PTC Therapeutics GlobeNewswire
Jul-17-20 12:00PM	7 New Stocks to Buy for 2021 and Beyond InvestorPlace
Jul-15-20 04:33PM	One Of The Biggest IPOs Of The Year Falls in Debut After Pricing High Investor's Business Daily
Jul-13-20 10:16AM	Royalty Pharmas Dazzling Debut Leads to Tepid Street Views Bloomberg -7.51%
Jul-02-20 01:02PM	Keep an Eye on Royalty Pharma Stock, 2020s Biggest IPO InvestorPlace
Jul-01-20 01:48PM	Dun & Bradstreet Trades Higher After IPO Raised $1.7 Billion Bloomberg
Jun-30-20 10:40AM	New Ventures Portfolio Company, ADC Therapeutics, Completes $267 Million IPO PR Newswire
Jun-27-20 07:13PM	Top Insider Buys Highlight for the Week of June 26 GuruFocus.com
Jun-26-20 04:42PM	Albertsons Falters in Debut After $800 Million IPO Letdown Bloomberg
Jun-25-20 07:01PM	Cerberus-Backed Albertsons Falls Short With $800 Million IPO Bloomberg
08:43AM	New Ventures Portfolio Company, Royalty Pharma, Surges On Public Debut PR Newswire
Jun-22-20 06:10PM	What to expect from the IPO market through the end of 2020 Yahoo Finance Video
Jun-18-20 04:15PM	Royalty Pharma Announces Closing of Initial Public Offering GlobeNewswire
12:37PM	PreMarket Prep Stock Of The Day: Royalty Pharma Benzinga
09:53AM	Morning Market Stats in 5 Minutes Benzinga
Jun-17-20 09:55AM	Morning Market Stats in 5 Minutes Benzinga +9.24%
06:06AM	IPO market braces for another busy week and Royalty Pharma becomes the biggest deal year-to-date MarketWatch
Jun-16-20 06:21PM	Royalty Pharma Soars 59% After Years Biggest U.S. IPO Bloomberg
05:34PM	Nasdaq President Nelson Griggs on the 2020 IPO market Yahoo Finance Video
04:21PM	Coronavirus update: Global case tally tops 8 million and states reopen businesses even as infections and hospitalizations rise MarketWatch
03:21PM	Royalty Pharma Jumps 58% From Its IPO. Thats More Money for Drug Research. Barrons.com
12:14PM	Royalty Pharma shares soar 57.1% in market debut Reuters
12:10PM	Royalty Pharma's stock soars in public debut, as Wall Street cheers the year's largest IPO MarketWatch
09:32AM	Royalty Pharma IPO Sets Record As Largest Public Offering This Year Investor's Business Daily
07:07AM	Royalty Pharma raises $2.2 billion in biggest IPO of the year so far MarketWatch
Jun-15-20 11:29PM	Royalty Pharma IPO Expanded to Raise Almost $2.2 Billion Bloomberg
07:21PM	Royalty Pharma IPO prices at top of range in biggest 2020 U.S. listing -sources Reuters

Royalty Pharma plc operates in the biopharmaceutical industry. The company operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry. It is involved in the identification, evaluation, and acquisition of royalties and royalty-related assets on various biopharmaceutical therapies. The company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio includes royalties on approximately 45 commercial products and three development-stage product candidates. The company has royalties on various therapeutic areas and drug classes, including Neulasta, Neupogen, Rituxan, Imbruvica, Trodelvy, Tazverik, and Xtandi in oncology; Lyrica in neuropathic pain; Biktarvy, Genvoya, Prezista, Symtuza, Truvada, and Atripla in HIV; Humira, Remicade, and Cimzia TNF inhibitors; Kalydeco, Orkambi, Symdeko, and Trikafta in cystic fibrosis; Tecfidera and Tysabri in multiple sclerosis; Emgality, Nurtec ODT (rimegepant), and vazegepant in migraine; and others. Royalty Pharma plc was founded in 1996 and is based in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ADAGE CAPITAL PARTNERS GP, L.L	10% Owner	Dec 18	Sale	44.02	101,050	4,448,221	38,714,280	Dec 18 02:36 PM
ADAGE CAPITAL PARTNERS GP, L.L	10% Owner	Dec 17	Sale	43.92	7,200,000	316,224,000	38,815,330	Dec 18 02:36 PM
RIGGS RORY B	Director	Oct 20	Sale	42.00	463,200	19,454,400	0	Oct 22 09:48 PM
Coyne Terrance P.	EVP & CFO	Jun 18	Buy	28.00	1,450	40,600	1,450	Jun 23 09:21 PM
Coyne Terrance P.	EVP & CFO	Jun 18	Buy	28.00	1,500	42,000	1,500	Jun 23 09:21 PM
RIGGS RORY B	Director	Jun 18	Buy	28.00	15,000	420,000	15,000	Jun 23 09:14 PM
Hite Christopher	EVP & Vice Chairman	Jun 18	Buy	28.00	70,000	1,960,000	70,000	Jun 23 09:13 PM
FORD WILLIAM E	Director	Jun 18	Buy	28.00	1,500,000	42,000,000	1,500,000	Jun 22 09:55 PM
Legorreta Pablo G.	CEO, Chairman of the Board	Jun 18	Buy	28.00	20,000	560,000	10,000	Jun 22 09:55 PM
Lloyd George W.	EVP, Investments & GC	Jun 18	Buy	28.00	11,200	313,600	11,200	Jun 22 09:54 PM
Lloyd George W.	EVP, Investments & GC	Jun 18	Buy	28.00	3,000	84,000	3,000	Jun 22 09:54 PM
Giuliani Mario Germano	Director	Jun 18	Buy	28.00	50,000	1,400,000	50,000	Jun 22 09:47 PM
ADAGE CAPITAL PARTNERS GP, L.L	10% Owner	Jun 18	Buy	28.00	3,000,000	84,000,000	46,015,330	Jun 22 05:31 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience